These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16941299)

  • 1. [Treatment of chronic plantar fasciitis with botulinum toxin A--an open pilot study on 25 patients with a 14-week-follow-up].
    Placzek R; Hölscher A; Deuretzbacher G; Meiss L; Perka C
    Z Orthop Ihre Grenzgeb; 2006; 144(4):405-9. PubMed ID: 16941299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is botulinum toxin A effective for the treatment of plantar fasciitis?
    Peterlein CD; Funk JF; Hölscher A; Schuh A; Placzek R
    Clin J Pain; 2012 Jul; 28(6):527-33. PubMed ID: 22673486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin A--therapy option in cases of chronic plantar fasciitis?--an open treatment attempt with 9 patients and a one year observation period].
    Z Orthop Ihre Grenzgeb; 2005; 143(2):145-8. PubMed ID: 15849625
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum toxin type A in chronic plantar fasciitis: clinical effects one year after injection.
    Díaz-Llopis IV; Gómez-Gallego D; Mondéjar-Gómez FJ; López-García A; Climent-Barberá JM; Rodríguez-Ruiz CM
    Clin Rehabil; 2013 Aug; 27(8):681-5. PubMed ID: 23411793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic plantar fasciitis with botulinum toxin A: an open case series with a 1 year follow up.
    Placzek R; Deuretzbacher G; Buttgereit F; Meiss AL
    Ann Rheum Dis; 2005 Nov; 64(11):1659-61. PubMed ID: 16227422
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of local anesthesia and energy level on the clinical outcome of extracorporeal shock wave-treatment of chronic plantar fasciitis].
    Labek G; Auersperg V; Ziernhöld M; Poulios N; Böhler N
    Z Orthop Ihre Grenzgeb; 2005; 143(2):240-6. PubMed ID: 15849646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled study of the efficacy of the injection of botulinum toxin type A versus corticosteroids in chronic plantar fasciitis: results at one and six months.
    Díaz-Llopis IV; Rodríguez-Ruíz CM; Mulet-Perry S; Mondéjar-Gómez FJ; Climent-Barberá JM; Cholbi-Llobel F
    Clin Rehabil; 2012 Jul; 26(7):594-606. PubMed ID: 22144721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of refractory, chronic low back pain with botulinum neurotoxin A: an open-label, pilot study.
    Jabbari B; Ney J; Sichani A; Monacci W; Foster L; Difazio M
    Pain Med; 2006; 7(3):260-4. PubMed ID: 16712627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
    Suputtitada A; Phanthumchinda K; Locharernkul C; Suwanwela NC
    J Med Assoc Thai; 2004 Oct; 87(10):1205-11. PubMed ID: 15560699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
    Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J
    J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A for the treatment of provoked vestibulodynia: an open-label, pilot study.
    Dykstra DD; Presthus J
    J Reprod Med; 2006 Jun; 51(6):467-70. PubMed ID: 16846084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
    Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
    Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
    Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin-A injections via electrical motor point stimulation to treat writer's cramp: pilot study.
    Lim EC; Quek AM; Seet RC
    Neurol Neurophysiol Neurosci; 2006 Jun; ():4. PubMed ID: 17260081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
    Yuan RY; Sheu JJ; Yu JM; Chen WT; Tseng IJ; Chang HH; Hu CJ
    Neurology; 2009 Apr; 72(17):1473-8. PubMed ID: 19246421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial.
    Singh JA; Mahowald ML; Noorbaloochi S
    Transl Res; 2009 May; 153(5):205-16. PubMed ID: 19375681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.